SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH L impact

FDA Grants Orphan Drug Designation to Hutchmed’s Sovleplenib

The designation is for treatment of autoimmune hemolytic anemia.

Related stories